-
Agonistic Anti-BTLA mAb (3C10) Induced Prolongation of Murine Cardiac Allograft and Generation of IL-10 Dependent Regulatory CD4+ T Cells, An
-
Alemtuzumab as Anti-Rejection Therapy in Kidney Transplant Patients Induces Homeostatic T Cell Proliferation and Impairs IL7 but Not IL2 Responses
-
Alemtuzumab for Induction Therapy for Small Bowel Transplantation
-
Alemtuzumab Induction and Belatacept-Based Immunosuppression in Renal Transplant Recipients: Peripheral Dynamics of T and B Cell Populations with Potential Regulatory Signatures
-
Alemtuzumab Induction and Steroid Free Maintenance in Predominately African American Renal Allograft Recipients
-
Alemtuzumab Induction in HCV Seropositive Kidney Transplant Recipients
-
Alemtuzumab Induction in Simultaneous Pancreas and Kidney Transplantation
-
Alemtuzumab Induction Results in Higher Rates of Leucopenia and Opportunistic Viral Infections in Renal Transplant Recipients
-
Alemtuzumab Induction with Tacrolimus Monotherapy vs TAC+MMF Bitherapy in Pancreas Transplant Recipients: 10 Year Experience
-
Alemtuzumab Mitigates the Risk of Early Rejection Associated with Delayed Graft Function in Deceased Donor Renal Transplantation
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 178
- Next Page »